128 related articles for article (PubMed ID: 37331169)
1. Design, synthesis and anticancer evaluation of novel oncolytic peptide-chlorambucil conjugates.
Yin H; Fu XY; Gao HY; Ma YN; Yao JF; Du SS; Qi YK; Wang KW
Bioorg Chem; 2023 Sep; 138():106674. PubMed ID: 37331169
[TBL] [Abstract][Full Text] [Related]
2. The hybrid oncolytic peptide NTP-385 potently inhibits adherent cancer cells by targeting the nucleus.
Yin H; Chen XT; Chi QN; Ma YN; Fu XY; Du SS; Qi YK; Wang KW
Acta Pharmacol Sin; 2023 Jan; 44(1):201-210. PubMed ID: 35794372
[TBL] [Abstract][Full Text] [Related]
3. Three Rounds of Stability-Guided Optimization and Systematical Evaluation of Oncolytic Peptide LTX-315.
Fu XY; Yin H; Chen XT; Yao JF; Ma YN; Song M; Xu H; Yu QY; Du SS; Qi YK; Wang KW
J Med Chem; 2024 Mar; 67(5):3885-3908. PubMed ID: 38278140
[TBL] [Abstract][Full Text] [Related]
4. Cross-linking of the DNA repair protein Omicron6-alkylguanine DNA alkyltransferase to DNA in the presence of antitumor nitrogen mustards.
Loeber R; Michaelson E; Fang Q; Campbell C; Pegg AE; Tretyakova N
Chem Res Toxicol; 2008 Apr; 21(4):787-95. PubMed ID: 18324787
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic journery of nitrogen mustard as alkylating anticancer agents: Historic to future perspectives.
Singh RK; Kumar S; Prasad DN; Bhardwaj TR
Eur J Med Chem; 2018 May; 151():401-433. PubMed ID: 29649739
[TBL] [Abstract][Full Text] [Related]
6. Potentiation of chlorambucil cytotoxicity in B-cell chronic lymphocytic leukemia by inhibition of DNA-dependent protein kinase activity using wortmannin.
Christodoulopoulos G; Muller C; Salles B; Kazmi R; Panasci L
Cancer Res; 1998 May; 58(9):1789-92. PubMed ID: 9581813
[TBL] [Abstract][Full Text] [Related]
7. Chlorambucil-conjugated platinum(IV) prodrugs to treat triple-negative breast cancer in vitro and in vivo.
Ma ZY; Wang DB; Song XQ; Wu YG; Chen Q; Zhao CL; Li JY; Cheng SH; Xu JY
Eur J Med Chem; 2018 Sep; 157():1292-1299. PubMed ID: 30195239
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of chlorambucil-induced DNA lesion formation and repair in a spectrum of different human cell systems.
Krassnig SC; Mäser M; Probst NA; Werner J; Schlett C; Schumann N; von Scheven G; Mangerich A; Bürkle A
Toxicol Rep; 2023; 10():171-189. PubMed ID: 36714466
[TBL] [Abstract][Full Text] [Related]
9. Enthalpy-driven nuclease-like activity and mechanism of peptide-chlorambucil conjugates.
Yang RC; Huang JT; Chen YL; Hung CC; Liao M; Yao WC; Chen CH; Liou CC; Waring MJ; Sheh L
Org Biomol Chem; 2014 Jul; 12(27):4890-904. PubMed ID: 24874710
[TBL] [Abstract][Full Text] [Related]
10.
Vats K; Satpati D; Sharma R; Kumar C; Sarma HD; Dash A
J Labelled Comp Radiopharm; 2017 Jul; 60(9):431-438. PubMed ID: 28545160
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and structural optimization of oncolytic peptide LTX-315.
Song M; Liu Q; Yao JF; Wang YT; Ma YN; Xu H; Yu QY; Li Z; Du SS; Qi YK
Bioorg Med Chem; 2024 Jun; 107():117760. PubMed ID: 38762978
[TBL] [Abstract][Full Text] [Related]
12. Linker structure-activity relationships in fluorodeoxyglucose chlorambucil conjugates for tumor-targeted chemotherapy.
El Hilali M; Reux B; Debiton E; Leal F; Galmier MJ; Vivier M; Chezal JM; Miot-Noirault E; Coudert P; Weber V
Bioorg Med Chem; 2017 Oct; 25(20):5692-5708. PubMed ID: 28927903
[TBL] [Abstract][Full Text] [Related]
13. DNA-Dependent protein kinase activity correlates with clinical and in vitro sensitivity of chronic lymphocytic leukemia lymphocytes to nitrogen mustards.
Muller C; Christodoulopoulos G; Salles B; Panasci L
Blood; 1998 Oct; 92(7):2213-9. PubMed ID: 9746757
[TBL] [Abstract][Full Text] [Related]
14. Chlorambucil in chronic lymphocytic leukemia: mechanism of action.
Begleiter A; Mowat M; Israels LG; Johnston JB
Leuk Lymphoma; 1996 Oct; 23(3-4):187-201. PubMed ID: 9031099
[TBL] [Abstract][Full Text] [Related]
15. PNA-nitrogen mustard conjugates are effective suppressors of HER-2/neu and biological tools for recognition of PNA/DNA interactions.
Zhilina ZV; Ziemba AJ; Nielsen PE; Ebbinghaus SW
Bioconjug Chem; 2006; 17(1):214-22. PubMed ID: 16417271
[TBL] [Abstract][Full Text] [Related]
16. Homologous recombinational repair vis-à-vis chlorambucil resistance in chronic lymphocytic leukemia.
Bello VE; Aloyz RS; Christodoulopoulos G; Panasci LC
Biochem Pharmacol; 2002 May; 63(9):1585-8. PubMed ID: 12007561
[TBL] [Abstract][Full Text] [Related]
17. Chlorambucil cytotoxicity in malignant B lymphocytes is synergistically increased by 2-(morpholin-4-yl)-benzo[h]chomen-4-one (NU7026)-mediated inhibition of DNA double-strand break repair via inhibition of DNA-dependent protein kinase.
Amrein L; Loignon M; Goulet AC; Dunn M; Jean-Claude B; Aloyz R; Panasci L
J Pharmacol Exp Ther; 2007 Jun; 321(3):848-55. PubMed ID: 17351105
[TBL] [Abstract][Full Text] [Related]
18. Chlorambucil induction of HsRad51 in B-cell chronic lymphocytic leukemia.
Christodoulopoulos G; Malapetsa A; Schipper H; Golub E; Radding C; Panasci LC
Clin Cancer Res; 1999 Aug; 5(8):2178-84. PubMed ID: 10473103
[TBL] [Abstract][Full Text] [Related]
19. Nitrogen mustard drug resistant B-cell chronic lymphocytic leukemia as an in vivo model for crosslinking agent resistance.
Bramson J; McQuillan A; Aubin R; Alaoui-Jamali M; Batist G; Christodoulopoulos G; Panasci LC
Mutat Res; 1995 May; 336(3):269-78. PubMed ID: 7739615
[TBL] [Abstract][Full Text] [Related]
20. Reduced DNA double strand breaks in chlorambucil resistant cells are related to high DNA-PKcs activity and low oxidative stress.
Boldogh I; Roy G; Lee MS; Bacsi A; Hazra TK; Bhakat KK; Das GC; Mitra S
Toxicology; 2003 Nov; 193(1-2):137-52. PubMed ID: 14599773
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
